Results 11 to 20 of about 451,989 (311)

An Empirical Biomarker-based Calculator for Autosomal Recessive Polycystic Kidney Disease - The Nieto-Narayan Formula [PDF]

open access: yes, 2016
Autosomal polycystic kidney disease (ARPKD) is associated with progressive enlargement of the kidneys fuelled by the formation and expansion of fluid-filled cysts. The disease is congenital and children that do not succumb to it during the neonatal period will, by age 10 years, more often than not, require nephrectomy+renal replacement therapy for ...
Goldberg, Itzhak D.   +3 more
arxiv   +12 more sources

Reverse Phenotyping Maternal Cystic Kidney Disease by Diagnosis in a Newborn: Case Report and Literature Review on Neonatal Cystic Kidney Diseases

open access: yesActa Medica Lituanica, 2021
Kidney cysts are the most common kidney lesion, while congenital kidney cysts are mostly found in pediatric population. Neonatal kidney cysts can develop due to fetal malformations, rare genetic disorders or can be acquired which is very rare.
Dovilė Ruzgienė   +4 more
doaj   +1 more source

Polycystic Kidney Disease [PDF]

open access: yesNew England Journal of Medicine, 1989
The Polycystic Kidney Disease (PKD) is a genetic disease which is characterized by the gradual emergence of cystic lesions in the kidneys, which replace the renal parenchyma causing deterioration of its function to stage 5. The PKD is one of the causes of Chronic Kidney Disease on renal replacement therapy (RRT).
Lavie, C.J.   +3 more
openaire   +4 more sources

Polycystic Kidney Disease [PDF]

open access: yesPediatrics In Review, 2009
1. Jacques Benun, MD 2. Carol Lewis, MD 1. Hasbro Children's Hospital Providence, RI Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): The New Horizon For Children Who Have DPKD . Rizk D, Chapman A. Pediatr Nephrol. 2008;23 :1029– 1036[OpenUrl][1][CrossRef][2][PubMed][3] Autosomal Recessive Polycystic Kidney Disease ...
Carol Lewis, Jacques Benun
  +9 more sources

Polycystic Kidney Disease [PDF]

open access: yesJournal of the American Society of Nephrology, 2007
Renal cysts are common clinical findings, often incidentally discovered in the course of evaluating other problems. They may be either acquired or seen in association with a number of inherited and congenital disorders. The most common disorder, autosomal dominant polycystic kidney disease (ADPKD), is an important cause of end-stage renal disease (ESRD)
Stefan Somlo, Peter Igarashi
openaire   +2 more sources

Polycystic Kidney Disease [PDF]

open access: yesThe Journal of Clinical Hypertension, 2005
Polycystic kidney disease, an inherited systemic disorder, is characterized by the development of multiple cysts in the kidneys and other organs. Patients can present at any age, but more often come to clinical attention (unless there is a family history) after age 30. Patients who are diagnosed before age 30 have a worse renal survival.
L. Michael Prisant, Pamela J. Fall
openaire   +3 more sources

Predictors and outcomes of laparoscopic nephrectomy in autosomal dominant polycystic kidney disease [PDF]

open access: yesInvestigative and Clinical Urology, 2018
Purpose: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease, and 20% of patients eventually require nephrectomies due to compressive symptoms or renal-related complications. Traditionally, nephrectomies were
Kenneth Chen   +5 more
doaj   +1 more source

The emerging role of cellular senescence in renal diseases [PDF]

open access: yes, 2020
Cellular senescence represents the state of irreversible cell cycle arrest during cell division. Cellular senescence not only plays a role in diverse biological events such as embryogenesis, tissue regeneration and repair, ageing and tumour occurrence ...
Alpini, Gianfranco   +12 more
core   +1 more source

Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop.

open access: yesAmerican Journal of Kidney Diseases, 2020
The omission of outcomes that are of relevance to patients, clinicians and regulators across trials in autosomal dominant polycystic kidney disease (ADPKD) limits shared decision-making. The Standardized Outcomes in Nephrology - Polycystic Kidney Disease
Yeoungjee Cho   +30 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy